Lower risk of severe hypoglycaemia with insulin glargine 300 U/ mL versus glargine 100 U/ mL in participants with type 1 diabetes: A meta‐analysis of 6‐month phase 3 clinical trials-Reference-Cited by-同舟云学术

Lower risk of severe hypoglycaemia with insulin glargine 300 U/ mL versus glargine 100 U/ mL in participants with type 1 diabetes: A meta‐analysis of 6‐month phase 3 clinical trials

Published:2020-07-21 Issue:10 Volume:22 Page:1880-1885
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Danne Thomas¹^ORCID,Matsuhisa Munehide²,Sussebach Christian³,Goyeau Harmonie⁴,Lauand Felipe⁵,Niemoeller Elisabeth³,Bolli Geremia B.⁶^ORCID

Affiliation:

1. Children's Hospital Auf der Bult Hannover Medical School Hannover Germany

2. Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences Tokushima University Tokushima Japan

3. Sanofi Frankfurt am Main Germany

4. Sanofi Chilly‐Mazarin France

5. Sanofi Paris France

6. Section of Endocrinology and Metabolism, Department of Medicine Perugia University Medical School Perugia Italy

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14109

Reference15 articles.

1. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

2. Fear of hypoglycaemia and self-management in type 1 diabetes

3. Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil

4. New insulin glargine 300 Units. mL‐1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units. mL‐1;Becker RH;Diabetes Care,2015

5. Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study;Diabetes Technology & Therapeutics;2024-07-01

2. Impact of the basal/bolus ratio on continuous glucose monitoring parameters in patients with type 1 diabetes;Diabetes, Obesity and Metabolism;2024-06-03

3. Evolution of insulin therapy: past, present, future;Problems of Endocrinology;2024-01-24

4. Use of Second-Generation Basal Insulin Gla-300 in Special Populations: A Narrative Mini-Review;Current Diabetes Reviews;2023-11

5. Clinical impact after implementing an insulin protocol involving a switch to insulin glargine 300 U/ml as basal insulin for inpatient glycaemic control: A retrospective single-centre study;Journal of Diabetes and its Complications;2023-09